Abstract
Over the past few years, compelling evidence has emerged in support of the hierarchic cancer stem cell (CSC) model for many solid tumors, including hepatocellular cancers. We have recently identified a CSC gene signature that exhibited a pernicious interaction with a variety of key oncogenic and common stemness pathways. Among these common pathways, activation of NF-kB signaling was consistently observed in human liver CSCs. Based on these data, we hypothesized that NF-kB may be a specific therapeutic target against CSC. In this study, we evaluated whether the inhibition of NF-kB would selectively deplete liver CSC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
